USH201H - Biosensors from membrane proteins reconstituted in polymerized lipid bilayers - Google Patents

Biosensors from membrane proteins reconstituted in polymerized lipid bilayers Download PDF

Info

Publication number
USH201H
USH201H US06/768,650 US76865085A USH201H US H201 H USH201 H US H201H US 76865085 A US76865085 A US 76865085A US H201 H USH201 H US H201H
Authority
US
United States
Prior art keywords
stimulus
bilayer
lipid bilayer
membrane proteins
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US06/768,650
Inventor
Paul Yager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Government
US Department of Navy
Original Assignee
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Government filed Critical US Government
Priority to US06/768,650 priority Critical patent/USH201H/en
Assigned to UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE reassignment UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: YAGER, PAUL
Application granted granted Critical
Publication of USH201H publication Critical patent/USH201H/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/002Electrode membranes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438Electrodes

Definitions

  • This invention pertains generally to biosensors and more particularly to biosensors made by incorporating membrane proteins into polymerized lipid bilayers.
  • Biological cells have proteins in the cell membrane which react with molecules or other stimuli from outside the cell.
  • the proteins sense the presense of an external stimulus and change the characteristics of the cell membrane, typically making the membrane more or less permeable to external molecules or ions. These proteins, therefore, function as biosensors for the cell by sensing the presence of stimuli in the cell's environment.
  • Such a seal allows the recording of the current flow through single ion channels with time response in the sub-millisecond range.
  • This technique has the major advantage over the BLM and BFM techniques that it is much easier to form bilayers on the glass pipette tips.
  • the lifetime of bilayers on the pipettes may be no longer than that in the BLM and BFM techniques, the ability to pull off the old pipette and put on a new one and immediately get a new working patch without having to clean out the apparatus makes the patch pipette technique far easier to use as a research technique. It has recently been shown that the glass of the pipette can be used to form good seals to artificial lipid monolayers on water, from which good patches form with useful electrical properties.
  • a lipid membrane is, therefore, needed which can be produced quickly and easily and overcome the poor longevity and durability of BLMs, BFMs, and patches. Improvement in the longevity and durability of the lipid membrane would provide a practical sensor which could be used in the laboratory and in the field.
  • the object of the present invention to provide a polymerized lipid membrane which extends the longevity and durability of lipid bilayers used in biosensors.
  • the acetylcholine receptor protein is purified by affinity chromatography, reincorporated into lipid vesicles of polymerized lipids, and mounted on a glass microelectrode to produce a lipid bilayer containing the reincorporated proteins.
  • One electrode from the silver-silver chloride pair is mounted on each side of the bilayer. The electrodes can measure the change in current across the bilayer when the acetylcholine receptor protein is effected by cholinergic agonists.
  • FIG. 1 is a diagram of a patch clamp-based biosensor for monitoring the concentration of chemicals in a solution.
  • a rugged biosensing device and method which can be made specifically sensitive to any external stimulus such as vapors, dissolved compounds or other physical influence, for which there exists an appropriate membrane protein.
  • Electrically active biological membrane proteins are isolated and subsequently reincorporated into planar lipid bilayers, preferably using polymerizable lipids.
  • One or more bilayers are mounted on an appropriate device such that current and voltage changes across the membrane may be recorded. Binding of ligands to the proteins triggers either leakage of ions down concentration gradients or the pumping of charged ions from one side of the membrane to the other.
  • a variety of proteins and mounting arrangements are possible including placement of the membrane at the end of a length of hollow optical fiber through which an electrode is passed. Such an electrode could be used for highly localized in vivo measurement of chemicals including neurotransmitters, drugs and toxins.
  • the sensor devices of the present invention consist of a polymerizable lipid bilayer (containing active membrane proteins) which separates two aqueous electrolyte-filled compartments. Each compartment contains a non-polarizable electrode which is used to sense the conductivity of the membrane.
  • the polymerizable lipids form a bilayer in which the active membrane proteins that have been extracted from biological cells are reincorporated.
  • the lipids must be compatible with the function of the protein, and in the completed device the lipids must be polymerized.
  • the polymerization itself may occur either before the device is assembled, or after the assembly.
  • Polymerization can be by any means including chemical reactions, UV light, or with visible light after self-sensitization.
  • Any polymerizable lipid or mixture of polymerizable lipids with other non-polymerizable lipids can be used to form the bilayer but di-(10,12-tricosadiyuoyl) phosphatidylcholine and di-(10,12-uncosadiyuoyl) phosphatidylcholine are preferred.
  • Other diacetylene-containing lipids including sulfolipids, polymerizable diene lipids, and polymerizable methacrylate lipids can be used to form the bilayer.
  • Other heterogeneous combinations of non-polymerizable phospholipids and polymerizable lipids can also be used to form the bilayer.
  • a pure polymerizable lipid is most preferred.
  • the reincorporated active membrane proteins which may be either pumps or gates, cause a change in conductivity in the membrane or pump charged particles across the membrane in response to molecules that effect the proteins.
  • the membrane's conductivity can be monitored by either current flow across the membrane or a change in the voltage across the membrane.
  • the membrane patch is supported on a partition that may either be hydrophobic, as are those used in BLM and BFM technique, or hydrophilic, as is the glass pipette used in patch electrode work.
  • the partition that supports the membrane defines two aqueous compartments, one of which may be accessible to the environment.
  • a set of two electrodes, one on each side of the membrane measures the current and/or voltage across the membrane.
  • An appropriate electrical measuring device such as those currently commercially available for patch clamping experiments, must be attached to the electrodes.
  • a shield which protects the fragile polymerized bilayer from mechanical contact with external surfaces is used to encase the membrane.
  • this shield might consist of simple porous screen or a semipermeable membrane such as a dialysis membrane.
  • the shield must keep the membrane wet while letting through the compound to be sensed.
  • the basic function of the shield is to keep a specific environment close to the bilayer but to prevent damage to the bilayer.
  • FIG. 1 A diagrammatic representation of a patch clamp-based biosensor to be used for monitoring the concentration of molecules in solution as shown in FIG. 1.
  • the internal 10 and external 12 aqueous compartments are separated by the glass microelectrode tip 8 and the bilayer 20, which contains reincorporated active membrane proteins 26.
  • the shield 24 protects the membrane and allows permeation of the relevant chemicals from the environment 14 into the membrane's external aqueous compartment 12 through a semipermeable section 18.
  • Two silver-silver chloride electrodes 16, 22 allow electrical monitoring of the current flow through the membrane. For use of such an electrode for monitoring compounds from the air, the only modification would be that the external electrode 22 would be contained within the extra-membrane space 12 and that the shield 24 would not be permeable to water.
  • AChR acetylcholine receptor
  • the desired orientation of the protein in the surface monolayer would be obtained by only passing the electrode once through the interface of the lipid-protein mixture, while the other pass of the electrode would be through a pure polymerizable lipid monolayer. While still under the surface of the buffer, the lipids would be polymerized, followed by the insertion of the tip of the electrode into a shield which simultaneously provides a mechanical barrier protecting the bilayer and also serves to create an isolated aqueous space outside the electrode interior. This space could be contained within a semipermeable membrane such as a dialysis membrane which would contain a solution of acetylcholinesterase.
  • this enzyme would serve the function as does the acetylcholinesterase in the synaptic cleft i.e., to prevent the AChR from becoming saturated into the desensitized state in the constant presence of low levels of neurotransmitter.
  • This AChR electrode would respond with increased current flow through the membrane in the presence of cholinergic agonists, and, being composed of the same components as the post-synaptic membrane of the cholinergic synapse, would also detect antagonists and toxins for that system with the same specificity as the nerves themselves.
  • the size of the electrode tip need only be a few microns in diameter as long as the semipermeable membrane containing the cholinesterase could be made that small.
  • Such an electrode on the end of a hollow optical fiber could be inserted into a live animal or human to detect the levels of cholinergic agonists in vivo.
  • a striking example is in case of detection of neutrotoxins such as organophosphates.
  • the existing sensors often give false positives in the presence of non-toxic phosphate-containing compounds.
  • a sensor based on the acetylcholine receptor and cholinesterase, such as the one we have described, would only respond to those compounds which are toxic to the tissue from which they are derived, i.e. nerve and muscle tissue.
  • the response of the detectors can be in milliseconds after the binding of the target chemical. Further, more than one type of membrane protein can be reincorporated in a single detector, making a single electrical measurement capable of detecting any of several chemicals of interest.
  • the small size of the patch clamp pipette tip allows localization of the source of chemicals to within a few micrometers, if necessary.
  • the polymerized bilayers may be mounted in any practical configuration to give low or high surface area depending on the needs of the detection scheme.
  • a device could be produced by reincorporating proteins sensitive to the hazardous gases in workplaces. The device could provide a warning when toxic gases have escaped into the work environment.
  • the device can also be used to conduct in vivo analysis for many different molecules by reincorporating a membrane protein that reacts to a molecule in the present in vivo.
  • the size of the detector area could vary greatly with the type of application required. To produce a high current flow for easy detectability, a large number of proteins and consequently a large surface area would be required. Such large surface areas would be made possible by the strength of the polymerized bilayers. Alternatively, where small size detectors are preferable, it has been shown by the patch clamp technique that a 2 micrometer membrane size is adequate to produce measurable signals from as few as one protein molecule.

Abstract

A compact and portable biosensor which can detect the presense of an environmental stimulus is produced by extracting cell membrane proteins which are specific for the stimulus, purifying the proteins, and reincorporating the proteins into synthetic membranes. Electrodes are used to measure the voltage or current changes across the membrane when the proteins in the synthetic membranes react to the specific stimulus. The magnitude of the changes indicate the concentration of the stimulus in the environment.

Description

BACKGROUND TO THE INVENTION
This invention pertains generally to biosensors and more particularly to biosensors made by incorporating membrane proteins into polymerized lipid bilayers.
Biological cells have proteins in the cell membrane which react with molecules or other stimuli from outside the cell. The proteins sense the presense of an external stimulus and change the characteristics of the cell membrane, typically making the membrane more or less permeable to external molecules or ions. These proteins, therefore, function as biosensors for the cell by sensing the presence of stimuli in the cell's environment.
Many biophysical techniques have been developed to study the proteins which make up the membranes of biological cells. Among the most powerful of these techniques has been the isolation of membrane proteins, followed by reincorporation of the purified polypeptide into a synthetic membrane system in which the function can be studied in the absence of the frenetic activity which characterizes most native membrane preparations.
Reincorporation of proteins into synthetic membranes has most often been into vesicular membrane systems since they form spontaneously, provide an inside and outside aqueous space to probe, and can be stable for a long time. However, when access to the electrical activity of a membrane protein in a reconstituted system is required, most reconstituting vesicular membrane systems have compartments which are too small for convenient insertion of recording microelectrodes. The "black lipid membrane", or BLM, has offered an alternative solution. It allows transfer of protein from vesicles into a planar lipid bilayer separating two large aqueous compartments into which electrodes may be inserted for electrical measurement.
Montal and Mueller developed a method to form bilayers from monolayers on the surface of water. M. Montal and P. Mueller, Proc. Nat. Acad. Sci. U.S.A., 69, 3561-3566 (1972). This method for making bilayers from monolayers (BFM) allows formation of bilayers in the absence of organic solvents which contaminate an otherwise cleanly-reconstituted system. As it is usually practiced, the method enables one to produce a bilayer patch half a millimeter or so in diameter. This technique is, however, frustrating even for its most avid advocates, and additionally, once formed, the bilayer is only stable for a few minutes or hours at the most.
Recently, a new method, the patch clamp technique, was developed. O. P. Hamill, A. Marty, E. Neher, B. Sakmann, F. J. Sigworth, Pflugers Arch., 391, 85-100 (1981). In the patch clamp technique, a glass micropipette with a tip diameter of about 2 micrometers is placed against an existing bilayer or is moved through an air-water interface on which a monolayer exists. R. Coronado and R. Latorre, Biophys. J., 43, 231-236 (1983). This technique results in the formation and sealing of a bilayer across the pipette tip. The resulting bilayer can have a resistance in excess of 10 gigaohms. Such a seal allows the recording of the current flow through single ion channels with time response in the sub-millisecond range. This technique has the major advantage over the BLM and BFM techniques that it is much easier to form bilayers on the glass pipette tips. Although the lifetime of bilayers on the pipettes may be no longer than that in the BLM and BFM techniques, the ability to pull off the old pipette and put on a new one and immediately get a new working patch without having to clean out the apparatus makes the patch pipette technique far easier to use as a research technique. It has recently been shown that the glass of the pipette can be used to form good seals to artificial lipid monolayers on water, from which good patches form with useful electrical properties.
Many different membrane proteins have been monitored electrically using the above techniques. Among these are various neurotransmitter receptors, such as the acetylcholine receptor, visual proteins such as rhodopsin, and the bacterial proton pump bacteriorhodopsin. It has also been shown that sensory tissue, such as olfactory tissue, when presented to a BLM in such a manner that some of it is reincorporated into the bilayer, can induce an odor-dependent current flow across the membrane. V. Vodyanoy and R. B. Murphy, Science, 220, 717-19 (1983).
The generally short life of bilayers formed by all of the above-mentioned techniques has been an experimental annoyance that has hampered progress in the development of biosensors. Sensors produced with the above techniques would be easy to disrupt, mechanically limited to use in the laboratory, and have a short life span.
A lipid membrane is, therefore, needed which can be produced quickly and easily and overcome the poor longevity and durability of BLMs, BFMs, and patches. Improvement in the longevity and durability of the lipid membrane would provide a practical sensor which could be used in the laboratory and in the field.
SUMMARY OF THE INVENTION
It is, therefore, the object of the present invention to provide a polymerized lipid membrane which extends the longevity and durability of lipid bilayers used in biosensors.
It is another object of the present invention to provide a device which is portable and can be used in the field.
It is another object of the present invention to provide a quick and easy method for producing rugged biochemical sensors.
These and other objects are achieved by extracting membrane proteins from biological cells, reincorporating the proteins into a lipid bilayer, contacting the bilayer containing the membrane proteins with the environment containing the stimulus, and measuring the change in voltage or conductivity across the bilayer. The voltage or conductivity change indicates the presence of the stimulus and the magnitude of the voltage or conductivity change indicates the amount of the stimulus present. The polymerized lipid membrane provides a rugged suport for the proteins that function to sense molecules in the external environment.
In the preferred embodiment, the acetylcholine receptor protein is purified by affinity chromatography, reincorporated into lipid vesicles of polymerized lipids, and mounted on a glass microelectrode to produce a lipid bilayer containing the reincorporated proteins. One electrode from the silver-silver chloride pair is mounted on each side of the bilayer. The electrodes can measure the change in current across the bilayer when the acetylcholine receptor protein is effected by cholinergic agonists.
Other objects, advantages, and novel features of the present invention will become apparent from the following detailed description of the invention.
DESCRIPTION OF THE DRAWINGS
FIG. 1 is a diagram of a patch clamp-based biosensor for monitoring the concentration of chemicals in a solution.
DETAILED DESCRIPTION OF THE INVENTION
A rugged biosensing device and method is disclosed which can be made specifically sensitive to any external stimulus such as vapors, dissolved compounds or other physical influence, for which there exists an appropriate membrane protein. Electrically active biological membrane proteins are isolated and subsequently reincorporated into planar lipid bilayers, preferably using polymerizable lipids. One or more bilayers are mounted on an appropriate device such that current and voltage changes across the membrane may be recorded. Binding of ligands to the proteins triggers either leakage of ions down concentration gradients or the pumping of charged ions from one side of the membrane to the other. A variety of proteins and mounting arrangements are possible including placement of the membrane at the end of a length of hollow optical fiber through which an electrode is passed. Such an electrode could be used for highly localized in vivo measurement of chemicals including neurotransmitters, drugs and toxins.
The sensor devices of the present invention consist of a polymerizable lipid bilayer (containing active membrane proteins) which separates two aqueous electrolyte-filled compartments. Each compartment contains a non-polarizable electrode which is used to sense the conductivity of the membrane. The polymerizable lipids form a bilayer in which the active membrane proteins that have been extracted from biological cells are reincorporated. The lipids must be compatible with the function of the protein, and in the completed device the lipids must be polymerized.
Many polymerized lipids have been synthesized and used for a number of research purposes. Bilayers of such lipids can be mechanically stronger, less susceptible to perturbation by solvents, and nearly unaffected by temperature. The stabilization is accomplished by converting the van der Waals forces which hold normal bilayers together to the covalent forces seen in the polymers. It has been shown that membrane proteins can function when reincorporated in vesicles of polymerizable lipids as monomers, and even after polymerization with UV light. P. Yager, Biophys. J., 47, 93a (1985). It has also been shown that some polymerizable lipids can form stable patches, and BLMs. R. Benz. W. Press and H. Ringsdorf, Angew. Chem. Suppl. 869-880 (1982). They are logical candidates for the "ruggedization" of the reincorporated BLM, BFM or patch membrane system.
The polymerization itself may occur either before the device is assembled, or after the assembly. Polymerization can be by any means including chemical reactions, UV light, or with visible light after self-sensitization. C. Bubeck. B. Tiecke and G. Wegner, Ber. Bunsenges. Phys. Chem., 86, 495-498 (1982) or in the presence of sensitizing dyes. C. Bubeck. B. Tiecke and G. Wegner, Ber. Bunsenges. Phys. Chem., 86, 499-504 (1982). Visible and ultra-violet light are preferred, with visible light being most preferred. Any polymerizable lipid or mixture of polymerizable lipids with other non-polymerizable lipids can be used to form the bilayer but di-(10,12-tricosadiyuoyl) phosphatidylcholine and di-(10,12-uncosadiyuoyl) phosphatidylcholine are preferred. Other diacetylene-containing lipids including sulfolipids, polymerizable diene lipids, and polymerizable methacrylate lipids can be used to form the bilayer. Other heterogeneous combinations of non-polymerizable phospholipids and polymerizable lipids can also be used to form the bilayer. A pure polymerizable lipid, however, is most preferred.
The reincorporated active membrane proteins, which may be either pumps or gates, cause a change in conductivity in the membrane or pump charged particles across the membrane in response to molecules that effect the proteins. In either case, the membrane's conductivity can be monitored by either current flow across the membrane or a change in the voltage across the membrane.
The membrane patch is supported on a partition that may either be hydrophobic, as are those used in BLM and BFM technique, or hydrophilic, as is the glass pipette used in patch electrode work. The partition that supports the membrane defines two aqueous compartments, one of which may be accessible to the environment. A set of two electrodes, one on each side of the membrane, measures the current and/or voltage across the membrane. An appropriate electrical measuring device, such as those currently commercially available for patch clamping experiments, must be attached to the electrodes.
A shield which protects the fragile polymerized bilayer from mechanical contact with external surfaces is used to encase the membrane. Where the sensors are to be used in aqueous solutions, this shield might consist of simple porous screen or a semipermeable membrane such as a dialysis membrane. When the sensors are to be used to measure the concentrations of chemicals in air, the shield must keep the membrane wet while letting through the compound to be sensed. The basic function of the shield is to keep a specific environment close to the bilayer but to prevent damage to the bilayer.
A diagrammatic representation of a patch clamp-based biosensor to be used for monitoring the concentration of molecules in solution as shown in FIG. 1. The internal 10 and external 12 aqueous compartments are separated by the glass microelectrode tip 8 and the bilayer 20, which contains reincorporated active membrane proteins 26. The shield 24 protects the membrane and allows permeation of the relevant chemicals from the environment 14 into the membrane's external aqueous compartment 12 through a semipermeable section 18. Two silver- silver chloride electrodes 16, 22 allow electrical monitoring of the current flow through the membrane. For use of such an electrode for monitoring compounds from the air, the only modification would be that the external electrode 22 would be contained within the extra-membrane space 12 and that the shield 24 would not be permeable to water.
An example of a type of sensor which might be designed is one based on an acetylcholine receptor. In this sensor the receptor, AChR, would be purified by affinity chromatography and reincorporated into lipid vesicles of polymerized lipids. If the proper conditions are used the orientation of the protein in the liposomes can be better than 90% oriented in one direction. These vesicles would then be used to produce a high surface pressure monolayer at the air-water interface which can be used for preparation of bilayers on the electrode tip. The electrode used would be either a glass pipette pulled as in standard patch clamping technique, or a section of hollow glass fiber the tip of which would be pulled down to a 2 micrometer diameter opening. The desired orientation of the protein in the surface monolayer would be obtained by only passing the electrode once through the interface of the lipid-protein mixture, while the other pass of the electrode would be through a pure polymerizable lipid monolayer. While still under the surface of the buffer, the lipids would be polymerized, followed by the insertion of the tip of the electrode into a shield which simultaneously provides a mechanical barrier protecting the bilayer and also serves to create an isolated aqueous space outside the electrode interior. This space could be contained within a semipermeable membrane such as a dialysis membrane which would contain a solution of acetylcholinesterase. In this electrode system this enzyme would serve the function as does the acetylcholinesterase in the synaptic cleft i.e., to prevent the AChR from becoming saturated into the desensitized state in the constant presence of low levels of neurotransmitter.
This AChR electrode would respond with increased current flow through the membrane in the presence of cholinergic agonists, and, being composed of the same components as the post-synaptic membrane of the cholinergic synapse, would also detect antagonists and toxins for that system with the same specificity as the nerves themselves. The size of the electrode tip need only be a few microns in diameter as long as the semipermeable membrane containing the cholinesterase could be made that small. Such an electrode on the end of a hollow optical fiber could be inserted into a live animal or human to detect the levels of cholinergic agonists in vivo.
Several uses and advantages exist for this kind of sensor over those now in existence. A striking example is in case of detection of neutrotoxins such as organophosphates. The existing sensors often give false positives in the presence of non-toxic phosphate-containing compounds. A sensor based on the acetylcholine receptor and cholinesterase, such as the one we have described, would only respond to those compounds which are toxic to the tissue from which they are derived, i.e. nerve and muscle tissue.
The response of the detectors can be in milliseconds after the binding of the target chemical. Further, more than one type of membrane protein can be reincorporated in a single detector, making a single electrical measurement capable of detecting any of several chemicals of interest. The small size of the patch clamp pipette tip allows localization of the source of chemicals to within a few micrometers, if necessary. As previously mentioned, the polymerized bilayers may be mounted in any practical configuration to give low or high surface area depending on the needs of the detection scheme.
This class of devices has many different potential applications. A device could be produced by reincorporating proteins sensitive to the hazardous gases in workplaces. The device could provide a warning when toxic gases have escaped into the work environment. The device can also be used to conduct in vivo analysis for many different molecules by reincorporating a membrane protein that reacts to a molecule in the present in vivo. The size of the detector area could vary greatly with the type of application required. To produce a high current flow for easy detectability, a large number of proteins and consequently a large surface area would be required. Such large surface areas would be made possible by the strength of the polymerized bilayers. Alternatively, where small size detectors are preferable, it has been shown by the patch clamp technique that a 2 micrometer membrane size is adequate to produce measurable signals from as few as one protein molecule.
Obviously many modifications and variations of the present invention are possible in light of the above teachings. It is therefore to be understood that within the scope of the appended claims the invention may be practiced otherwise than as specifically described.

Claims (15)

What is claimed and desired to be secured by Letters Patent of the United States is:
1. A method for detecting a stimulus such as vapors or dissolved compounds, comprising the steps of:
extracting membrane proteins which react to said stimulus from biological cells;
reincorporating said membrane proteins into a lipid bilayer, said bilayer being mounted so as to create an external compartment and an internal compartment, said external compartment being accessible to the environment containing said stimulus;
contacting said bilayer containing said membrane proteins with the environment containing said stimulus; and
measuring the change in voltage or conductivity across said bilayer, said voltage or conductivity change indicating the presence of said stimulus, the magnitude of said voltage or conductivity change indicating the amount of said stimulus present.
2. The method of claim 1 wherein said lipid bilayer in said reincorporating step consists esentially of polymerizable lipids.
3. The method of claim 2 wherein said polymerizable lipids are selected from the group consisting of di-(10,12-tricosadiynoyl) phosphatidylcholine and di-(10,12-uncosadiynoyl) phosphatidylcholine.
4. The method of claim 1 wherein said membrane proteins in said reincorporating step are acetylcholine receptor proteins.
5. The method of claim 1 wherein said voltage or conductivity in said measuring step is measured using an electrode pair.
6. The method of claim 5 wherein said electrode pair is a silver-silver chloride electrode pair.
7. A biosensing device suitable for detecting a stimulus such as vapors or dissolved compounds, comprising:
means for supporting a lipid bilayer;
a lipid bilayer mounted on said supporting means, said suporting means and lipid bilayer creating an external compartment and an internal compartment, said external compartment being accessible to the environment containing said stimulus;
membrane proteins which react specifically to said stimulus, said membrane proteins having been extracted from biological cell membranes, purified, and reincorporated into said lipid bilayer;
means for facilitating the measurement of the current or voltage change across said lipid bilayer; and
a shield that surrounds said supporting means and mounted bilayer for protecting said microelectrode and bilayer from external disruption, said shield having a semipermeable section in one end to allow access to the external environment.
8. The device of claim 7 wherein said lipid bilayer consists esentially of polymerizable lipids.
9. The device of claim 8 wherein said polymerizable lipids are selected from the group consisting of di-(10,12-tricosadiynoyl) phosphatidylcholine and di-(10,12-uncosadiynoyl) phosphatidylcholine.
10. The device of claim 7 wherein said means for supporting a lipid bilayer is a glass microelectrode.
11. The device of claim 7 wherein said means for facilitating the measurement of the current or voltage change across said lipid bilayer is an electrode pair.
12. The device of claim 11 wherein said electrode pair is a silver-silver chloride electrode pair.
13. The device of claim 7 wherein said membrane proteins are acetylcholine receptor proteins.
14. A biosensing device suitable for detecting a stimulus such as vapors or dissolved compounds, comprising:
a glass microelectrode having an opening at one end;
a polymerizable lipid bilayer for containing reincorporated membrane proteins mounted over said opening at one end of said microelectrode, said polymerizable lipid bilayer creating an internal compartment and an external compartment;
acetylcholine receptor membrane proteins which have been extracted from biological cell membranes, purified, and reincorporated into said polymerizable lipid bilayer;
a silver-silver chloride electrode pair, the first electrode of said pair being mounted in the internal compartment of said glass microelectrode, the second electrode of said electrode pair being mounted in the external compartment to said microelectrode tip, said external compartment being accessible to the environment containing said stimulus; and
a shield surrounding said microelectrode tip and mounted bilayer for protecting said microelectrode and polymerized bilayer from external disruption, said shield having a semipermable section in one end to allow access to the external environment.
15. The method of claim 14 wherein said polymerizable lipids are selected from the group consisting of di-(10,12-tricosadiynoyl) phosphatidylcholine and di-(10,12-uncosadiynoyl) phosphatidylcholine.
US06/768,650 1985-08-23 1985-08-23 Biosensors from membrane proteins reconstituted in polymerized lipid bilayers Abandoned USH201H (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/768,650 USH201H (en) 1985-08-23 1985-08-23 Biosensors from membrane proteins reconstituted in polymerized lipid bilayers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/768,650 USH201H (en) 1985-08-23 1985-08-23 Biosensors from membrane proteins reconstituted in polymerized lipid bilayers

Publications (1)

Publication Number Publication Date
USH201H true USH201H (en) 1987-01-06

Family

ID=25083103

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/768,650 Abandoned USH201H (en) 1985-08-23 1985-08-23 Biosensors from membrane proteins reconstituted in polymerized lipid bilayers

Country Status (1)

Country Link
US (1) USH201H (en)

Cited By (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410356A1 (en) * 1989-07-24 1991-01-30 Anritsu Corporation Taste sensing system using artificial lipid membranes
US5001048A (en) * 1987-06-05 1991-03-19 Aurthur D. Little, Inc. Electrical biosensor containing a biological receptor immobilized and stabilized in a protein film
USH1212H (en) 1988-09-29 1993-07-06 The United States Of America As Represented By The Secretary Of The Army Generic detection with a receptor-based fiber optic sensor
US5302262A (en) * 1990-07-04 1994-04-12 Anritsu Corporation Taste sensing method for discriminating in detail taste of substances with high reproducibility by using artificial lipid membranes
WO1994025862A1 (en) * 1993-05-04 1994-11-10 Washington State University Research Foundation Biosensor substrate for mounting bilayer lipid membrane containing a receptor
US5368712A (en) * 1989-11-02 1994-11-29 Synporin Technologies, Inc. Biologically mimetic synthetic ion channel transducers
US5380651A (en) * 1990-12-31 1995-01-10 The Johns Hopkins University Method of determining odorant compounds and antagonists of odorants using a primary culture of olfactory neurons
WO1995016206A1 (en) * 1993-12-06 1995-06-15 Biosystems Technology Corporation Composition and method for detection of analytes
EP0687911A2 (en) 1988-06-23 1995-12-20 Associates Of Cape Cod, Inc. Methods for assaying endotoxin concentration
US5571568A (en) * 1989-06-15 1996-11-05 Biocircuits Corporation Multilayered bioelectronic sensors
US5736342A (en) * 1993-09-21 1998-04-07 Washington State University Research Foundation Biosensor for detecting the presence of chosen analytes
US6056922A (en) * 1996-05-30 2000-05-02 Sanyo Electric Co., Ltd Bilayer membrane device
US6123819A (en) * 1997-11-12 2000-09-26 Protiveris, Inc. Nanoelectrode arrays
WO2000079257A1 (en) * 1999-06-22 2000-12-28 President And Fellows Of Harvard College Molecular and atomic scale evaluation of biopolymers
US6267872B1 (en) * 1998-11-06 2001-07-31 The Regents Of The University Of California Miniature support for thin films containing single channels or nanopores and methods for using same
US20040110205A1 (en) * 2002-09-23 2004-06-10 Hui Wang Methods and systems for nanopore data analysis
US6824659B2 (en) 1997-07-25 2004-11-30 University Of Massachusetts Designed protein pores as components for biosensors
US20050053961A1 (en) * 1995-03-17 2005-03-10 Mark Akeson Characterization of individual polymer molecules based on monomer-interface interactions
US20060003458A1 (en) * 2003-08-15 2006-01-05 Golovchenko Jene A Study of polymer molecules and conformations with a nanopore
US20060014013A1 (en) * 2001-03-10 2006-01-19 Saavedra Steven S Stabilized biocompatible supported lipid membrane
US20060228402A1 (en) * 2005-04-08 2006-10-12 Charite-Universitatsmedizin Berlin Techniques for forming a lipid bilayer membrane
US20060251709A1 (en) * 2003-09-19 2006-11-09 Toru Ide Artificial lipid bilayer double-membrane forming device and artificial lipid double-membrane forming method of utilizing the same
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070124218A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20070124175A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware. Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US7238485B2 (en) 2004-03-23 2007-07-03 President And Fellows Of Harvard College Methods and apparatus for characterizing polynucleotides
US20070190542A1 (en) * 2005-10-03 2007-08-16 Ling Xinsheng S Hybridization assisted nanopore sequencing
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20080003307A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US20080033762A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to transmission of nutraceutical associated information
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20080047230A1 (en) * 2006-06-14 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20080103746A1 (en) * 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20080178692A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic methods
US20080182339A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods for allergen detection
US20080179255A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic devices
US20080181821A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Microfluidic chips for allergen detection
US20080181816A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Systems for allergen detection
US20080180259A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Devices for allergen detection
US20080241000A1 (en) * 2007-03-27 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for pathogen detection
US20080241910A1 (en) * 2007-03-27 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Devices for pathogen detection
US20080245740A1 (en) * 2007-01-29 2008-10-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic methods
US20090050569A1 (en) * 2007-01-29 2009-02-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic methods
US20090215157A1 (en) * 2007-03-27 2009-08-27 Searete Llc Methods for pathogen detection
US20100096268A1 (en) * 2008-09-03 2010-04-22 Nabsys, Inc. Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels
US20100147450A1 (en) * 2005-07-29 2010-06-17 The University Of Tokyo Method of forming bilayer membrane by contact between amphipathic monolayers and apparatus therefor
US20100243449A1 (en) * 2009-03-27 2010-09-30 Oliver John S Devices and methods for analyzing biomolecules and probes bound thereto
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US8455260B2 (en) 2009-03-27 2013-06-04 Massachusetts Institute Of Technology Tagged-fragment map assembly
US8715933B2 (en) 2010-09-27 2014-05-06 Nabsys, Inc. Assay methods using nicking endonucleases
US8828211B2 (en) 2010-06-08 2014-09-09 President And Fellows Of Harvard College Nanopore device with graphene supported artificial lipid membrane
US8859201B2 (en) 2010-11-16 2014-10-14 Nabsys, Inc. Methods for sequencing a biomolecule by detecting relative positions of hybridized probes
US8926813B2 (en) 2008-09-03 2015-01-06 Nabsys, Inc. Devices and methods for determining the length of biopolymers and distances between probes bound thereto
US8986528B2 (en) 1995-03-17 2015-03-24 President And Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
US9051609B2 (en) 2007-10-01 2015-06-09 Nabsys, Inc. Biopolymer Sequencing By Hybridization of probes to form ternary complexes and variable range alignment
EP3021106A3 (en) * 2001-07-30 2016-07-27 Meso Scale Technologies, LLC Methods of using assay electrode having immobilized lipid/protein layers for luminescence test measurements
US9650668B2 (en) 2008-09-03 2017-05-16 Nabsys 2.0 Llc Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels
US9914966B1 (en) 2012-12-20 2018-03-13 Nabsys 2.0 Llc Apparatus and methods for analysis of biomolecules using high frequency alternating current excitation
US10001496B2 (en) 2007-01-29 2018-06-19 Gearbox, Llc Systems for allergen detection
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US10294516B2 (en) 2013-01-18 2019-05-21 Nabsys 2.0 Llc Enhanced probe binding
US11274341B2 (en) 2011-02-11 2022-03-15 NABsys, 2.0 LLC Assay methods using DNA binding proteins

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"Reconstitution of Bacteriorhodopsin in a Polymerizable Lecithin" Paul Yager, submitted to Biochim. Biophys. Acta. Jul. 1985.
Angew. Chem. Suppl. 869-880 (1982), R. Benz, W. Press and H. Ringsdorf, "Black Lipid Membranes from Polymerizable Lipids".
Ber. Bunsenges, Phys. Chem., 86, 495-498 (1982) "Selfsensitization of the Photopolymerization of Diacetylenes Studied in Multilayers," C. Bubeck, B. Tieke, and G. Wegner.
Ber. Bunsenges, Phys. Chem., 86, 499-504, "Cyanine Dyes as Sensitizers of the Photopolymerization of Diacetylenes in Multilayers," C. Bubeck, B. Tieke, and G. Wegner (1982).
Biophys. J., 47, 93a (1985), "Patch Clamping of Bacteriorhodopsin and its Reconstitution in a Polymerizable Lechithin," Paul Yager.
Pflugers Arch., 391, 85-100 (1981) "Improved Patch-Clamp Techniques for High Resolution Current Recording from Cells and Cell-Free Membrane Patches," O. P. Hamill, A. Marty, E. Neher, B. Sakmann and F. J. Sigworth pp. 481-496.
Proc. Nat. Acad. Sci. USA, vol 69, No. 12, pp. 3561-3566, Dec. 1972 "Formation of Bimolecular Membranes from Lipid Monolayers and a Study of Their Electrical Properties," M. Montal and P. Mueller.
Science, 220 717-19 (1983), "Formation in Vitro Sperm Pronuclei and Mitotic Chromosomes Induced by Amphibian Ooplasmic Components" Vitaly Vodyanoy and Randall B. Murphy.

Cited By (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001048A (en) * 1987-06-05 1991-03-19 Aurthur D. Little, Inc. Electrical biosensor containing a biological receptor immobilized and stabilized in a protein film
EP0687911A2 (en) 1988-06-23 1995-12-20 Associates Of Cape Cod, Inc. Methods for assaying endotoxin concentration
USH1212H (en) 1988-09-29 1993-07-06 The United States Of America As Represented By The Secretary Of The Army Generic detection with a receptor-based fiber optic sensor
US5571568A (en) * 1989-06-15 1996-11-05 Biocircuits Corporation Multilayered bioelectronic sensors
US5622872A (en) * 1989-06-15 1997-04-22 Biocircuits Corporation Analyte detection through observed optical modulation of polymerized lipid layers
EP0410356A1 (en) * 1989-07-24 1991-01-30 Anritsu Corporation Taste sensing system using artificial lipid membranes
US5482855A (en) * 1989-07-24 1996-01-09 Anritsu Corporation Taste sensing system using artificial lipid membranes
US5368712A (en) * 1989-11-02 1994-11-29 Synporin Technologies, Inc. Biologically mimetic synthetic ion channel transducers
US5302262A (en) * 1990-07-04 1994-04-12 Anritsu Corporation Taste sensing method for discriminating in detail taste of substances with high reproducibility by using artificial lipid membranes
US5380651A (en) * 1990-12-31 1995-01-10 The Johns Hopkins University Method of determining odorant compounds and antagonists of odorants using a primary culture of olfactory neurons
WO1994025862A1 (en) * 1993-05-04 1994-11-10 Washington State University Research Foundation Biosensor substrate for mounting bilayer lipid membrane containing a receptor
US5736342A (en) * 1993-09-21 1998-04-07 Washington State University Research Foundation Biosensor for detecting the presence of chosen analytes
WO1995016206A1 (en) * 1993-12-06 1995-06-15 Biosystems Technology Corporation Composition and method for detection of analytes
US20050053961A1 (en) * 1995-03-17 2005-03-10 Mark Akeson Characterization of individual polymer molecules based on monomer-interface interactions
US20070281329A1 (en) * 1995-03-17 2007-12-06 President And Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
US8986528B2 (en) 1995-03-17 2015-03-24 President And Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
US9046483B2 (en) 1995-03-17 2015-06-02 President And Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
US7189503B2 (en) 1995-03-17 2007-03-13 President And Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
US6056922A (en) * 1996-05-30 2000-05-02 Sanyo Electric Co., Ltd Bilayer membrane device
US6824659B2 (en) 1997-07-25 2004-11-30 University Of Massachusetts Designed protein pores as components for biosensors
US20050131211A1 (en) * 1997-07-25 2005-06-16 Hagan Bayley Designed protein pores as components for biosensors
US6325904B1 (en) 1997-11-12 2001-12-04 Protiveris, Inc. Nanoelectrode arrays
US6123819A (en) * 1997-11-12 2000-09-26 Protiveris, Inc. Nanoelectrode arrays
EP1135676A4 (en) * 1998-11-06 2002-04-03 Univ California A miniature support for thin films containing single channels or nanopores and methods for using same
US6267872B1 (en) * 1998-11-06 2001-07-31 The Regents Of The University Of California Miniature support for thin films containing single channels or nanopores and methods for using same
US6746594B2 (en) 1998-11-06 2004-06-08 The Regents Of The University Of California Miniature support for thin films containing single channels or nanopores and methods for using the same
EP1135676A1 (en) * 1998-11-06 2001-09-26 The Regents of the University of California A miniature support for thin films containing single channels or nanopores and methods for using same
WO2000079257A1 (en) * 1999-06-22 2000-12-28 President And Fellows Of Harvard College Molecular and atomic scale evaluation of biopolymers
US20060014013A1 (en) * 2001-03-10 2006-01-19 Saavedra Steven S Stabilized biocompatible supported lipid membrane
EP3021106A3 (en) * 2001-07-30 2016-07-27 Meso Scale Technologies, LLC Methods of using assay electrode having immobilized lipid/protein layers for luminescence test measurements
US20040110205A1 (en) * 2002-09-23 2004-06-10 Hui Wang Methods and systems for nanopore data analysis
US7846738B2 (en) 2003-08-15 2010-12-07 President And Fellows Of Harvard College Study of polymer molecules and conformations with a nanopore
US20060003458A1 (en) * 2003-08-15 2006-01-05 Golovchenko Jene A Study of polymer molecules and conformations with a nanopore
US8969091B2 (en) 2003-08-15 2015-03-03 President And Fellows Of Harvard College Study of polymer molecules and conformations with a nanopore
US8394640B2 (en) 2003-08-15 2013-03-12 President And Fellows Of Harvard College Study of polymer molecules and conformations with a nanopore
US20060251709A1 (en) * 2003-09-19 2006-11-09 Toru Ide Artificial lipid bilayer double-membrane forming device and artificial lipid double-membrane forming method of utilizing the same
US7858030B2 (en) * 2003-09-19 2010-12-28 Japan Science And Technology Agency Artificial lipid bilayer membrane formation device, artificial lipid bilayer membrane formation method, and usage thereof
US7625706B2 (en) 2004-03-23 2009-12-01 Agilent Technologies, Inc. Methods and apparatus for characterizing polynucleotides
US7238485B2 (en) 2004-03-23 2007-07-03 President And Fellows Of Harvard College Methods and apparatus for characterizing polynucleotides
US7947454B2 (en) 2004-03-23 2011-05-24 President And Fellows Of Harvard College Methods and apparatus for characterizing polynucleotides
US8673556B2 (en) 2004-03-23 2014-03-18 President And Fellows Of Harvard College Methods and apparatus for characterizing polynucleotides
US20060228402A1 (en) * 2005-04-08 2006-10-12 Charite-Universitatsmedizin Berlin Techniques for forming a lipid bilayer membrane
US8506905B2 (en) * 2005-07-29 2013-08-13 The University Of Tokyo Method of forming bilayer membrane by contact between amphipathic monolayers and apparatus therefor
US20100147450A1 (en) * 2005-07-29 2010-06-17 The University Of Tokyo Method of forming bilayer membrane by contact between amphipathic monolayers and apparatus therefor
US20070190542A1 (en) * 2005-10-03 2007-08-16 Ling Xinsheng S Hybridization assisted nanopore sequencing
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070124218A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20080183396A1 (en) * 2005-11-30 2008-07-31 Searete Llc, A Limited Libility Corporation Of The State Of Delaware Systems and methods for transmitting pathogen related information and responding
US20070124175A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware. Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080210748A1 (en) * 2005-11-30 2008-09-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware, Systems and methods for receiving pathogen related information and responding
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US20080033762A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to transmission of nutraceutical associated information
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20080103746A1 (en) * 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US7827042B2 (en) 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20080047230A1 (en) * 2006-06-14 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20080003307A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20090050569A1 (en) * 2007-01-29 2009-02-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic methods
US20080181816A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Systems for allergen detection
US10001496B2 (en) 2007-01-29 2018-06-19 Gearbox, Llc Systems for allergen detection
US20080245740A1 (en) * 2007-01-29 2008-10-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic methods
US20080180259A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Devices for allergen detection
US20080181821A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Microfluidic chips for allergen detection
US20080179255A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic devices
US20080178692A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic methods
US20080182339A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods for allergen detection
US8617903B2 (en) 2007-01-29 2013-12-31 The Invention Science Fund I, Llc Methods for allergen detection
US20080241935A1 (en) * 2007-03-27 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods for pathogen detection
US20080241000A1 (en) * 2007-03-27 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for pathogen detection
US20080241910A1 (en) * 2007-03-27 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Devices for pathogen detection
US20090215157A1 (en) * 2007-03-27 2009-08-27 Searete Llc Methods for pathogen detection
US9051609B2 (en) 2007-10-01 2015-06-09 Nabsys, Inc. Biopolymer Sequencing By Hybridization of probes to form ternary complexes and variable range alignment
US8882980B2 (en) 2008-09-03 2014-11-11 Nabsys, Inc. Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels
US8926813B2 (en) 2008-09-03 2015-01-06 Nabsys, Inc. Devices and methods for determining the length of biopolymers and distances between probes bound thereto
US9650668B2 (en) 2008-09-03 2017-05-16 Nabsys 2.0 Llc Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels
US20100096268A1 (en) * 2008-09-03 2010-04-22 Nabsys, Inc. Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels
US9719980B2 (en) 2008-09-03 2017-08-01 Nabsys 2.0 Llc Devices and methods for determining the length of biopolymers and distances between probes bound thereto
US8455260B2 (en) 2009-03-27 2013-06-04 Massachusetts Institute Of Technology Tagged-fragment map assembly
US20100243449A1 (en) * 2009-03-27 2010-09-30 Oliver John S Devices and methods for analyzing biomolecules and probes bound thereto
US8828211B2 (en) 2010-06-08 2014-09-09 President And Fellows Of Harvard College Nanopore device with graphene supported artificial lipid membrane
US9797863B2 (en) 2010-06-08 2017-10-24 President And Fellows Of Harvard College Graphene supported artificial membranes and uses thereof
US9434981B2 (en) 2010-09-27 2016-09-06 Nabsys 2.0 Llc Assay methods using nicking endonucleases
US8715933B2 (en) 2010-09-27 2014-05-06 Nabsys, Inc. Assay methods using nicking endonucleases
US9702003B2 (en) 2010-11-16 2017-07-11 Nabsys 2.0 Llc Methods for sequencing a biomolecule by detecting relative positions of hybridized probes
US8859201B2 (en) 2010-11-16 2014-10-14 Nabsys, Inc. Methods for sequencing a biomolecule by detecting relative positions of hybridized probes
US11274341B2 (en) 2011-02-11 2022-03-15 NABsys, 2.0 LLC Assay methods using DNA binding proteins
US9914966B1 (en) 2012-12-20 2018-03-13 Nabsys 2.0 Llc Apparatus and methods for analysis of biomolecules using high frequency alternating current excitation
US10294516B2 (en) 2013-01-18 2019-05-21 Nabsys 2.0 Llc Enhanced probe binding

Similar Documents

Publication Publication Date Title
USH201H (en) Biosensors from membrane proteins reconstituted in polymerized lipid bilayers
US20190242913A1 (en) Lipid bilayer sensor system
EP0986758B1 (en) Detection of biologically active molecules by use of pre-activated cell-based biosensors in liquid-based separation systems
Olefirowicz et al. Dopamine concentration in the cytoplasmic compartment of single neurons determined by capillary electrophoresis
US8784929B2 (en) Bilayers
Chen et al. Chemical analysis of single cells and exocytosis
US20140249056A1 (en) Bilayers
US20060251709A1 (en) Artificial lipid bilayer double-membrane forming device and artificial lipid double-membrane forming method of utilizing the same
Cans et al. Highlights of 20 years of electrochemical measurements of exocytosis at cells and artificial cells
Jin et al. Quantitative determination of glutathione in single human erythrocytes by capillary zone electrophoresis with electrochemical detection
Dong et al. Monitoring diclofenac sodium in single human erythrocytes introduced by electroporation using capillary zone electrophoresis with electrochemical detection
US20090294304A1 (en) Electrochemical sensor
Zhang et al. Analysis of amino acids in individual human erythrocytes by capillary electrophoresis with electroporation for intracellular derivatization and laser‐induced fluorescence detection
Mohammad et al. Protein sensing with engineered protein nanopores
JPH11299496A (en) Vessel for oocyte and measuring device using the same
Jardemark et al. Patch clamp detection in capillary electrophoresis
Pacáková et al. Validation of a method for determination of phospholipase A2 and melittin in bee venom preparations by capillary electrophoresis
EP1366353A2 (en) Electric substance detectors comprising cellular material
CN115728353B (en) Application of MscCG in preparation of kit for detecting valproic acid medicines
JP6964878B2 (en) Lipid bilayer property testing method, drug screening method, and lipid bilayer property analysis system
Yager et al. Development of ion-channel based biosensors using polymerizable lipids
US20010027927A1 (en) Method and device for the detection of not easily volatized substances
US20050106556A1 (en) Bio-sensors
JP2024051576A (en) MEASURING DEVICE, ITS MANUFACTURING METHOD, AND METHOD FOR MEASURING TEST SUBSTANCE USING THE MEASURING DEVICE
YAGER Biosensors from membrane proteins reconstituted in polymerized lipid bilayers(Patent Application)

Legal Events

Date Code Title Description
AS Assignment

Owner name: UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:YAGER, PAUL;REEL/FRAME:004452/0214

Effective date: 19850822

STCF Information on status: patent grant

Free format text: PATENTED CASE